Pressemitteilung BoxID: 299575 (aap Implantate AG)
  • aap Implantate AG
  • Lorenzweg 5
  • 12099 Berlin
  • Ansprechpartner
  • Marc Heydrich
  • +49 (30) 75019-134

aap signs exclusive license agreement for an IP-protected product of its biomaterial portfolio

(lifePR) (Berlin, ) aap Biomaterials GmbH, a subsidiary of aap Implantate AG, a medical technology company listed in the Frankfurt Stock Exchange's Prime Standard segment, today signed an exclusive license agreement with a world-leading medical technology company. aap has granted an exclusive license to an IP-protected product of its biomaterial portfolio and remains at the same time the product's manufacturer. The exclusive license relates to all product indications, excluding Dental, oral care and food additives and is valid worldwide except in the United States.

With the signing, aap will receive a one-time license fee of approx. EUR 2.1 million.